Literature DB >> 419430

The significance of urine phosphate measurements in the early diagnosis of intestinal infarction.

W G Jamieson, B M Taylor, M Troster, D Durand.   

Abstract

This study has confirmed previous experiments which indicated that inorganic phosphate concentrations rise in body fluids after intestinal infarction. The phosphate clearance ratio is elevated in dogs after occlusion of the superior mesenteric artery, but is not as sensitive as indicator of the presence of a necrotic intestine as the serum or peritoneal fluid phosphate levels. The rise and fall of phosphate levels occur within the first 24 hours after infarction, similar to amylase levels in acute pancreatitis. The renal failure observed in dogs after ligation of the superior mesenteric vein is likely on the basis of hypovolemia and does not seem to result from hyperphosphatemia. Intestinal infarction should be suspected with laboratory evidence of hemo-concentration, marked leukocytosis, an inappropriate metabolic acidosis and elevated serum and peritoneal fluid phosphate levels. In dogs with normal renal function, an elevated urinary phosphate clearance ratio of greater than 0.20, as measured on a spot sample of urine and serum, is also highly suggestive of the presence of this condition, but its absence, by no means, excludes the diagnosis. With these simple laboratory tests, possibly an earlier diagnosis can be made, and timely operation can be an entirely intestine-saving procedure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 419430

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  2 in total

1.  Inferior mesenteric venous sampling, pulse oximetry, and assessment of colonic perfusion during aortic aneurysm surgery.

Authors:  C P Delaney; N F Couse; D Mehigan; T V Keaveny
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Metabolomic markers for intestinal ischemia in a mouse model.

Authors:  René Fahrner; Diren Beyoğlu; Guido Beldi; Jeffrey R Idle
Journal:  J Surg Res       Date:  2012-08-25       Impact factor: 2.192

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.